These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 8812989)
1. Crystallization and preliminary X-ray diffraction studies of human cytochrome P450 reductase. Zhao Q; Smith G; Modi S; Paine M; Wolf RC; Tew D; Lian LY; Primrose WU; Roberts GC; Driessen HP J Struct Biol; 1996; 116(2):320-5. PubMed ID: 8812989 [TBL] [Abstract][Full Text] [Related]
2. Four crystal structures of the 60 kDa flavoprotein monomer of the sulfite reductase indicate a disordered flavodoxin-like module. Gruez A; Pignol D; Zeghouf M; Covès J; Fontecave M; Ferrer JL; Fontecilla-Camps JC J Mol Biol; 2000 May; 299(1):199-212. PubMed ID: 10860732 [TBL] [Abstract][Full Text] [Related]
3. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase. Roitel O; Scrutton NS; Munro AW Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506 [TBL] [Abstract][Full Text] [Related]
4. A second FMN binding site in yeast NADPH-cytochrome P450 reductase suggests a mechanism of electron transfer by diflavin reductases. Lamb DC; Kim Y; Yermalitskaya LV; Yermalitsky VN; Lepesheva GI; Kelly SL; Waterman MR; Podust LM Structure; 2006 Jan; 14(1):51-61. PubMed ID: 16407065 [TBL] [Abstract][Full Text] [Related]
5. Crystal structure of NAD(P)H:flavin oxidoreductase from Escherichia coli. Ingelman M; Ramaswamy S; Nivière V; Fontecave M; Eklund H Biochemistry; 1999 Jun; 38(22):7040-9. PubMed ID: 10353815 [TBL] [Abstract][Full Text] [Related]
6. Crystallization and preliminary X-ray analysis of cholesterol oxidase from Brevibacterium sterolicum containing covalently bound FAD. Croteau N; Vrielink A J Struct Biol; 1996; 116(2):317-9. PubMed ID: 8812988 [TBL] [Abstract][Full Text] [Related]
7. Kinetic, spectroscopic and thermodynamic characterization of the Mycobacterium tuberculosis adrenodoxin reductase homologue FprA. McLean KJ; Scrutton NS; Munro AW Biochem J; 2003 Jun; 372(Pt 2):317-27. PubMed ID: 12614197 [TBL] [Abstract][Full Text] [Related]
8. Atomic structure of ferredoxin-NADP+ reductase: prototype for a structurally novel flavoenzyme family. Karplus PA; Daniels MJ; Herriott JR Science; 1991 Jan; 251(4989):60-6. PubMed ID: 1986412 [TBL] [Abstract][Full Text] [Related]
9. Crystallization and preliminary crystallographic analysis of the major NAD(P)H: FMN oxidoreductase of Vibrio fischeri ATCC 7744. Koike H; Sasaki H; Tanokura M; Zenno S; Saigo K J Struct Biol; 1996; 117(1):70-2. PubMed ID: 8776889 [TBL] [Abstract][Full Text] [Related]
10. Heterologous expression of an endogenous rat cytochrome b(5)/cytochrome b(5) reductase fusion protein: identification of histidines 62 and 85 as the heme axial ligands. Davis CA; Dhawan IK; Johnson MK; Barber MJ Arch Biochem Biophys; 2002 Apr; 400(1):63-75. PubMed ID: 11913972 [TBL] [Abstract][Full Text] [Related]
11. Flavin-binding and protein structural integrity studies on NADPH-cytochrome P450 reductase are consistent with the presence of distinct domains. Narayanasami R; Horowitz PM; Masters BS Arch Biochem Biophys; 1995 Jan; 316(1):267-74. PubMed ID: 7840627 [TBL] [Abstract][Full Text] [Related]
12. Crystallization and preliminary crystallographic analysis of NADPH:FMN oxidoreductase from Vibrio harveyi. Tanner J; Lei B; Liu M; Tu SC; Krause KL J Mol Biol; 1994 Aug; 241(2):283-7. PubMed ID: 8057370 [TBL] [Abstract][Full Text] [Related]
13. Characterization of the FAD binding domain of cytochrome P450 reductase. Hodgson AV; Strobel HW Arch Biochem Biophys; 1996 Jan; 325(1):99-106. PubMed ID: 8554349 [TBL] [Abstract][Full Text] [Related]
14. Flavin reductase P: structure of a dimeric enzyme that reduces flavin. Tanner JJ; Lei B; Tu SC; Krause KL Biochemistry; 1996 Oct; 35(42):13531-9. PubMed ID: 8885832 [TBL] [Abstract][Full Text] [Related]
15. Crystal structure of the FMN-binding domain of human cytochrome P450 reductase at 1.93 A resolution. Zhao Q; Modi S; Smith G; Paine M; McDonagh PD; Wolf CR; Tew D; Lian LY; Roberts GC; Driessen HP Protein Sci; 1999 Feb; 8(2):298-306. PubMed ID: 10048323 [TBL] [Abstract][Full Text] [Related]
16. Three-dimensional structure of NADPH-cytochrome P450 reductase: prototype for FMN- and FAD-containing enzymes. Wang M; Roberts DL; Paschke R; Shea TM; Masters BS; Kim JJ Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8411-6. PubMed ID: 9237990 [TBL] [Abstract][Full Text] [Related]
17. Crystallization and preliminary X-ray diffraction studies of a protein disulfide oxidoreductase from Aquifex aeolicus. D'Ambrosio K; De Simone G; Pedone E; Rossi M; Bartolucci S; Pedone C Acta Crystallogr D Biol Crystallogr; 2004 Nov; 60(Pt 11):2076-7. PubMed ID: 15502332 [TBL] [Abstract][Full Text] [Related]
18. The interaction of NADPH-P450 reductase with P450: an electrochemical study of the role of the flavin mononucleotide-binding domain. Estabrook RW; Shet MS; Fisher CW; Jenkins CM; Waterman MR Arch Biochem Biophys; 1996 Sep; 333(1):308-15. PubMed ID: 8806785 [TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of a 5'-deazaFAD T491V NADPH-cytochrome P450 reductase. Zhang H; Gruenke L; Saribas AS; Im SC; Shen AL; Kasper CB; Waskell L Biochemistry; 2003 Jun; 42(22):6804-13. PubMed ID: 12779335 [TBL] [Abstract][Full Text] [Related]
20. Interflavin one-electron transfer in the inducible nitric oxide synthase reductase domain and NADPH-cytochrome P450 reductase. Yamamoto K; Kimura S; Shiro Y; Iyanagi T Arch Biochem Biophys; 2005 Aug; 440(1):65-78. PubMed ID: 16009330 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]